Clinical Trials Logo
  1. Home
  2. Acute Kidney Failure
  3. NCT02991742

Ioxaglate Versus Iodixanol for the Prevention of Contrast-induced Nephropathy in High-risk Patients (IDPC Trial) — IDPC  

Acute Kidney Failure Clinical Trial

Official title:
Ioxaglate Versus Iodixanol for the Prevention of Contrast-induced Nephropathy in High-risk Patients After Diagnostic and Therapeutic Cardiac Catheterization (IDPC Trial)

Clinical Trial Summary

Contrast media-induced nephropathy following diagnostic and therapeutic cardiac catheterization.

Clinical Trial Description

Contrast-induced acute kidney injury represents a serious complication of procedures requiring administration of iodinated contrast media and is associated with the need for dialysis, prolonged hospitalization, increased costs, and mortality.

Contrast-induced nephropathy is defined as an increase of 25% in serum creatinine before the procedure.

Iodixanol, a nonionic, dimeric, iso-osmolar contrast medium may be less nephrotoxic than low-osmolar contrast media in high-risk patients.

The purpose of this study is to compare iodixanol versus ioxaglate in high risk patients between 48 and 96 hours after procedures that use contrast. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02991742
Study type Observational
Source Instituto Dante Pazzanese de Cardiologia
Contact
Status Not yet recruiting
Phase N/A
Start date December 2016
Completion date November 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT00760591 - Change of Neutrophil Gelatinase-Associated Lipocalin(NGAL) Following Sodium Phosphate Bowel Preparation(Pilot Study) N/A
Completed NCT00890214 - Prostacyclin's Effect on Platelet Responsiveness Phase 4
Active, not recruiting NCT03675906 - The Relationship Between Hypoalbuminemia and Development of Acute Kidney Failure (AKI) According to KDIGO Criteria
Recruiting NCT04334707 - Kidney Precision Medicine Project
Active, not recruiting NCT04079829 - Postoperative Respiratory Abnormalities
Recruiting NCT00424320 - Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy Phase 3
Completed NCT00472563 - Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate Phase 2/Phase 3
Withdrawn NCT03846258 - High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy Phase 4
Completed NCT06358365 - Enhancing Fluid Transfer Through the Skin, by Increased Sweat Rate, on Hemodialysis Patients N/A
Completed NCT00252200 - BNP (Nesiritide) vs. Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery. Phase 1/Phase 2
Completed NCT04190979 - Clinical Application of the Medyria TrackCath System in Endovascular Repair of Abdominal Aortic Aneurysms (AAA) N/A
Completed NCT04917497 - Levosimendan Infusion in Critically Ill Patients With Cardiogenic Shock
Recruiting NCT05309291 - Theranova Randomized, Controlled, Trial (RCT) in China N/A
Completed NCT02486614 - Effect of Citrate on the Coagulation System in Patients Receiving CRRT
Active, not recruiting NCT02470507 - Immune Function in Acute Kidney Injury
Active, not recruiting NCT05384899 - Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol
Completed NCT06190522 - Diagnosis of Acute Obstructive Renal Failure by Clinical Ultrasound Performed by the Emergency Physician.
Recruiting NCT04221932 - Implementation of CRRT KPI Reports to Standardize and Improve the Quality of CRRT Delivery in Alberta "QUALITY CRRT"
Active, not recruiting NCT01122225 - Neutrophile Gelatinase Associated Lipocalin Evaluation in Septic Acute Kidney Injury N/A
Completed NCT00529139 - Hannover Dialysis Outcome Study Phase 4